Category: Life Sciences
Life Sciences market research reports by Euromonitor International
-
Rx/Reimbursement Adult Incontinence in Australia
While demand for rx/reimbursement adult incontinence in Australia continued to steadily rise in 2024, value growth was much higher. By increasing awareness and education among healthcare professionals, particularly in general practice settings, more individuals experiencing incontinence are being id ... Read More
-
Rx/Reimbursement Adult Incontinence in Kazakhstan
Rx/reimbursement adult incontinence in Kazakhstan continued to develop positively in 2024, with volume and current value growth rates improving from 2023. As was the case at the retail level, expansion was primarily driven by the fact that the incidence of incontinence problems in the country is inc ... Read More
-
Rx/Reimbursement Adult Incontinence in Turkey
Sales of Rx/reimbursement adult incontinence saw strong value growth in Turkey in 2024, with volume growth notably lower. This aligns with the cross-category trend of value being more strongly supported by high prices. Whilst retail adult incontinence saw stronger value growth in 2024, compared to R ... Read More
-
Menstrual Care in Uruguay
Menstrual care registered both healthy current value and volume growth in in Uruguay 2024. An improving economy, as well as a significant drop in cross-border shopping into Argentina (due to the appreciation of the Argentine peso), supported the positive performance. Euromonitor International's Mens ... Read More
-
Rx/Reimbursement Adult Incontinence in Serbia
Rx/reimbursement adult incontinence registered healthy current value and volume growth in Serbia in 2024, with an ageing population supporting growth. In addition, with consumer purchasing power under pressure, more users have sought medical prescriptions to help with the cost of adult incontinence. ... Read More
-
Menstrual Care in Uzbekistan
The rate of growth in retail current value sales of menstrual care slowed significantly but remained robust in 2024. Growth in retail volume sales continued to slow but remained moderate, supported by a steadily rising population of women aged 12-54 years and increased consumer education, especially ... Read More
-
Tissue and Hygiene in Bosnia and Herzegovina
Value sales of tissue and hygiene in Bosnia and Herzegovina continued to benefit from the lingering effects of inflation in 2024, which translated into significant product price increases. Whilst inflation slowed in the year, disposable incomes remained chronically low, limiting consumers’ ability t ... Read More
-
Rx/Reimbursement Adult Incontinence in Belgium
Value sales of prescription (RX) and reimbursement adult incontinence products increased in 2024, driven by several key factors. Firstly, Belgium's aging population continued to create consistent demand for these products. Additionally, the rising need for reimbursement for adult incontinence was ex ... Read More
-
Rx/Reimbursement Adult Incontinence in Spain
In 2024, reimbursement adult incontinence saw significant sales growth in Spain. The Spanish healthcare system has adopted a clear strategy by prioritising reimbursement for products specifically designed to manage severe incontinence. This framework reflects not only a commitment to improving patie ... Read More
-
Menstrual Care in Ukraine
Sales of menstrual care declined in current value and retail volume terms in 2024. Value sales declined at a slower rate than in volume terms but this was due to price increases linked to high inflation and the rising cost of logistics. Meanwhile, volume sales continued to be impacted by the fact th ... Read More
-
Rx/Reimbursement Adult Incontinence in Sweden
RX/reimbursement adult incontinence saw steady growth in value and volume terms in 2024. Value growth was primarily driven by two key factors: Sweden’s ageing population and the rising prevalence of obesity and type 2 diabetes. A strong correlation exists between age, underlying health conditions an ... Read More
-
Rx/Reimbursement Adult Incontinence in Poland
In 2024, Rx/reimbursement adult incontinence in Poland continued to post healthy retail volume and current value growth, albeit slower than in 2023 and other years of the review period. As in the retail sphere, demand increased alongside a growing number of consumers in older cohorts, who are more l ... Read More
-
Rx/Reimbursement Adult Incontinence in Slovakia
The landscape of Rx/reimbursement adult incontinence in Slovakia underwent notable changes in 2024 due to regulatory adjustments. From April 2024, new legislation was introduced to refine the prescription process, mandating that doctors indicate the specific level of incontinence on a designated vou ... Read More
-
Rx/Reimbursement Adult Incontinence in Hungary
Current value sales growth of Rx/reimbursement adult incontinence products in Hungary in 2024 was significantly higher compared to retail adult incontinence products. as local consumers could be reimbursed by up to 80% by insurance companies. Doctors determine the appropriate payment group for each ... Read More
-
Rx/Reimbursement Adult Incontinence in Norway
Value sales of RX/reimbursement adult incontinence increased in 2024, driven by an ageing population and a rising obesity rate. The natural expansion of the potential user base contributed to steady demand, while growing health consciousness and hygiene awareness further encouraged individuals to se ... Read More
-
Rx/Reimbursement Adult Incontinence in Denmark
Value sales of RX/reimbursement adult incontinence grew in 2024 in Denmark, supported by the ageing population. It is estimated that around 80% of reimbursement recipients are aged 65 and older, a group that is expanding as life expectancy increases. The ageing population, coupled with rising obesit ... Read More
-
Rx/Reimbursement Adult Incontinence in the Czech Republic
Rx/reimbursement adult incontinence saw volume and value growth in the Czech Republic in 2024. The growth of the category is being fuelled not just by the ageing population but also by more information about Rx rights and reimbursements via magazines and pharmacies. Since 1 January 2024, the VAT rat ... Read More
-
Rx/Reimbursement Adult Incontinence in the Netherlands
Value sales of RX/reimbursement adult incontinence increased modestly in 2024, but negative volume growth continued to exert downward pressure on overall performance. Many consumers opted to purchase incontinence products through retail channels or e-commerce platforms rather than rely on reimbursed ... Read More
-
Menstrual Care in Vietnam
Value sales of menstrual care products in Vietnam rose strongly 2024, driven by a slight increase in the female population (50.1% of the total), higher hygiene standards and increased awareness of proper menstrual care. Educational efforts in high schools addressing early sexual precocity have also ... Read More
-
Cannabis in Brazil
The year 2024 was one of the most dynamic for the cannabis industry in Brazil. In the medical segment, which is amongst the top 10 global markets in USD value, cannabis-based medications started to be distributed through the public health system of Brazil’s most populous state. Moreover, ANVISA (Bra ... Read More
-
Rx/Reimbursement Adult Incontinence in Colombia
Despite significant challenges within Colombia’s healthcare system – including government interventions affecting major EPS providers such as Sanitas, Nueva EPS, and Famisanar, as well as the financial struggles prompting Sura and Compensar to request withdrawal from the system – Rx/reimbursement in ... Read More
-
Cannabis in Poland
Poland is an established economic powerhouse in Eastern Europe. The country’s impressive growth rate over the past two decades has turned it into one of the most important economies in the whole of Europe, especially evident in the turbulent geopolitical climate. While currently the cannabis market ... Read More
-
Rx/Reimbursement Adult Incontinence in Italy
Rx/reimbursement adult incontinence continued to decline in both volume and current value terms in Italy in 2024 as the National Sanitary System lowered budgets to tackle the country’s massive debt. The basic comfort of these products, coupled with growing consumer acceptance of partial out-of-pocke ... Read More
-
Rx/Reimbursement Adult Incontinence in the US
Rx/reimbursement adult incontinence in the US maintained stable volume and current value growth in 2024. Nevertheless, post-pandemic, Medicaid disenrollment was underway, after three years of continuous enrolment. During the pandemic, states operated under a policy of continuous enrolment, which off ... Read More
-
Rx/Reimbursement Adult Incontinence in France
Value sales of Rx/reimbursement adult incontinence increased in 2024 in France, as did volume sales. In France, these products sustained a positive growth trend over the year, driven by their essential nature, which makes them difficult to substitute. Demand stems largely from an ageing population a ... Read More
Research Assistance
